Early effects of human papillomavirus vaccination in Belgium

被引：11

作者：

Merckx, Mireille ^{[1
,2
]}

Vanden Broeck, Davy ^{[1
]}

Benoy, Ina ^{[3
]}

Depuydt, Christophe ^{[3
]}

Weyers, Steven ^{[2
]}

Arbyn, Marc ^{[4
]}

机构：

[1] Univ Ghent, ICRH, B-9000 Ghent, Belgium

[2] Ghent Univ Hosp, Dept Obstet & Gynaecol, Ghent, Belgium

[3] Son Hlth Care AML, Antwerp, Belgium

[4] Sci Inst Publ Hlth, Canc Epidemiol Unit, Brussels, Belgium

来源：

EUROPEAN JOURNAL OF CANCER PREVENTION | 2015年 / 24卷 / 04期

关键词：

CROSS-PROTECTIVE EFFICACY; GRADE CERVICAL LESIONS; METAANALYSIS; PREVENTION; INFECTION; CANCER;

D O I：

10.1097/CEJ.0000000000000067

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Human papillomavirus (HPV) vaccination has been reimbursed in Belgium since 2007 for girls (12-15 years), extended to girls up to 18 years in 2008. This study assesses the trend of HPV 16/18 infections in women less than 25 years of age participating in opportunistic cervical cancer screening. A significant reduction in the prevalence of HPV 16 [relative risk (RR)=0.61, 95% confidence interval=0.39-0.95] and a nonsignificant reduction in HPV 18 (RR=0.65, 95% confidence interval=0.29-1.48) was found in the youngest group (15-19 years). The prevalences in the older age group did not change significantly. These findings show the early effects of HPV vaccination and confirm the effectiveness of immunization in a real-life setting.

引用

页码：340 / 342

页数：3

共 50 条

[31] Surveillance of effects of HPV vaccination in Belgium [J].

Arbyn, Marc ;

Vanden Broeck, Davy ;

Benoy, Ina ;

Bogers, Johannes ;

Depuydt, Christophe ;

Praet, Marleen ;

De Sutter, Philippe ;

Hoorens, Anne ;

Hauben, Esther ;

Poppe, Willy ;

Van Ranst, Marc ;

Delvenne, Philippe ;

Gofflot, Stephanie ;

Petein, Michel ;

Engelen, Frans ;

Vanneste, Alain ;

Op De Beeck, Lode ;

Van Damme, Pierre ;

Temmerman, Marleen ;

Weyers, Steven .

CANCER EPIDEMIOLOGY, 2016, 41 :152-158

[32] Human Papillomavirus Vaccination of Boys and Extended Catch-up Vaccination: Effects on the Resilience of Programs [J].

Elfstrom, K. Miriam ;

Lazzarato, Fulvio ;

Franceschi, Silvia ;

Dillner, Joakim ;

Baussano, Iacopo .

JOURNAL OF INFECTIOUS DISEASES, 2016, 213 (02) :199-205

[33] Current status of human papillomavirus vaccination [J].

Brotherton, Julia M. L. ;

Ogilvie, Gina S. .

CURRENT OPINION IN ONCOLOGY, 2015, 27 (05) :399-404

[34] Evaluating Human Papillomavirus Vaccination Programs [J].

Donovan, Basil ;

Guy, Rebecca J. .

SEXUALLY TRANSMITTED DISEASES, 2013, 40 (04) :290-291

[35] Human Papillomavirus Infection and Vaccination in Males [J].

Ventimiglia, Eugenio ;

Horenblas, Simon ;

Muneer, Asif ;

Salonia, Andrea .

EUROPEAN UROLOGY FOCUS, 2016, 2 (04) :355-362

[36] Knowledge of human papillomavirus (HPV) and HPV vaccination: An international comparison [J].

Marlow, Laura A. V. ;

Zimet, Gregory D. ;

McCaffery, Kirsten J. ;

Ostini, Remo ;

Waller, Jo .

VACCINE, 2013, 31 (05) :763-769

[37] Human papillomavirus vaccination: component of an integrated HIV prevention program? [J].

van der Loeff, Maarten F. Schim ;

Giuliano, Anna R. .

AIDS, 2012, 26 (17) :2251-2252

[38] A brief history of economic evaluation for human papillomavirus vaccination policy [J].

Beutels, Philippe ;

Jit, Mark .

SEXUAL HEALTH, 2010, 7 (03) :352-358

[39] Mathematical analysis of a human papillomavirus transmission model with vaccination and screening [J].

Zhang, Kai ;

Wang, Xinwei ;

Liu, Hua ;

Ji, Yunpeng ;

Pan, Qiuwei ;

Wei, Yumei ;

Ma, Ming .

MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2020, 17 (05) :5449-5476

[40] The estimated impact of natural immunity on the effectiveness of human papillomavirus vaccination [J].

Matthijsse, Suzette M. ;

Hontelez, Jan A. C. ;

Naber, Steffie K. ;

van Rosmalen, Joost ;

Rozemeijer, Kirsten ;

Penning, Corine ;

Bakker, Roel ;

van Ballegooijen, Marjolein ;

de Kok, Inge M. C. M. ;

de Vlas, Sake J. .

VACCINE, 2015, 33 (41) :5357-5364

← 1 2 3 4 5 →